Primary CNS Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Primary Central Nervous System Lymphoma
Condition: Primary Central Nervous System Lymphoma Interventions: Drug: ICP-022; Drug: Pemetrexed Sponsor: Henan Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2022 Category: Research Source Type: clinical trials
Prognosis Factors in Patients With Primary Central Nervous System Lymphoma
Conditions: PCNSL; Survival Analysis Intervention: Other: prognostic marker Sponsor: Zhengzhou University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2021 Category: Research Source Type: clinical trials
